International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Ketamine 50-mg/mL Injection

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2013 - Volume 17, Number 4
View All Articles in Issue

Page(s): 331

Note: Electronic version includes errata or revisions.

Download in electronic PDF format for $75

Abstract: A formulation for preparing Ketamine 50-mg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, formulation, ketamine, compounded sterile preparations, anesthesia, anesthetic, pain relief, analgesia, analgesic

Related Categories: FORMULATIONS, PAIN MANAGEMENT, PARENTERALS, STERILE PREPARATIONS, SURGERY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Ketamine 50-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2013 Pg. 331
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Rabi Joseph	Mar/Apr 2016 Pg. 107-113
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Ketamine for Pain in Hospice Patients Wood Robert M	Jul/Aug 2000 Pg. 253-254
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H	Mar/Apr 2018 Pg. 172-175
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle	Nov/Dec 2016 Pg. 517-520
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 512
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jul/Aug 2015 Pg. 295-300
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report McNulty Jack P, Hahn Kristian	Sep/Oct 2012 Pg. 364-368
Meperidine Hydrochloride 50-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2012 Pg. 423
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Topical Medications for Orofacial Neuropathic Pain Bramwell Bethany L	May/Jun 2010 Pg. 200-203
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Allen Loyd V Jr	May/Jun 2016 Pg. 231
Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse) Allen Loyd V Jr	Sep/Oct 2020 Pg. 406
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding Allen Loyd V Jr	May/Jun 2019 Pg. 221-228
Case Reports: Compounding to Relieve Arthritis Pain Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane	Nov/Dec 2008 Pg. 498-504
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice McNulty John P, Muller George	May/Jun 2014 Pg. 190-200
Return to Top